Seeing Is Believing

Currently out of the existing stock ratings of Bryan Spillane, 151 are a BUY (51.36%), 116 are a HOLD (39.46%), 27 are a SELL (9.18%).
Analyst Bryan Spillane, currently employed at BAML, carries an average stock price target met ratio of 68.7% that have a potential upside of 23.36% achieved within 387 days.
Bryan Spillane’s has documented 589 price targets and ratings displayed on 32 stocks. The coverage is on Consumer Defensive, Consumer Cyclical, Healthcare sectors.
Most recent stock forecast was given on FRPT, Freshpet at 01-Jul-2026.
Analyst best performing recommendations are on K (KELLANOVA).
The best stock recommendation documented was for K (KELLANOVA) at 8/2/2024. The price target of $70 was fulfilled within 3 days with a profit of $9.63 (15.95%) receiving and performance score of 53.17.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Nov-2020
$17
$5.26 (44.80%)
$17
1 months 5 days ago
(10-Sep-2026)
3/9 (33.33%)
$3.76 (28.40%)
165
Buy Since 17-May-2024
$18
$5.74 (46.82%)
$15
1 years 11 months 9 days ago
(06-Nov-2024)
2/3 (66.67%)
$3.9 (27.66%)
632
Buy Since 26-Oct-2020
$12
$0.26 (2.21%)
$15
2 years 9 months 23 days ago
(22-Dec-2023)
3/6 (50%)
$1.8 (17.65%)
459
Hold Since 14-Sep-2021
$12
$0.26 (2.21%)
$12
3 years 1 months 3 days ago
(12-Sep-2023)
7/7 (100%)
$3.23 (36.83%)
82
Buy Since 27-Oct-2020
$16
$4.26 (36.29%)
$20
3 years 7 months 5 days ago
(10-Mar-2023)
2/6 (33.33%)
$5.58 (53.55%)
51
Which stock is Bryan Spillane most bullish on?
Which stock is Bryan Spillane most reserved on?
What Year was the first public recommendation made by Bryan Spillane?